13th Annual Updates in the Treatment and Management of Hematologic Malignancies Highlights from San Diego
The 13th Annual Updates in the Treatment and Management of Hematologic Malignancies Highlights from San Diego provides an invaluable educational experience highlighting the latest advances in malignant and non-malignant hematology. Please join us to engage with experts and other healthcare professionals to learn and gain practical insights on current therapies, and innovative treatments.
This activity has been designed to meet the educational needs of hematologist, oncologist and advanced practice providers that are involved in the care of patients with hematologic malignancies.
At the conclusion of this activity, participants should be able to:
• Evaluate new induction therapies for transplant eligible and ineligible patients
• Assess T- cell redirecting treatment in relapsed MM
Diffuse B-Cell Lymphoma
• Identify evolving standards of care for aggressive lymphoma including new agents
• Describe the role of immunotherapy in Hodgkin and Non-Hodgkin Lymphoma
Chronic Lymphocytic Leukemia
• Establish the changing standards of care to initial and subsequent treatment with novel targeted agents
• Assess the role of evolving therapies for malignant B-cell including recent FDA approvals
• Explain the advances in the novel therapeutic strategies in the newly diagnosed and relapsed acute leukemias
• Asses new developments in the field of cellular therapies for acute leukemias
Accreditation: The HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation: The HCA Healthcare Continental Division designates this live activity for a maximum of 3.00 AMA PRA Category 1TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Commercial Support: This Activity was developed without support from any ineligible company.*The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company.
Disclosure: The HCA Healthcare Continental Division is committed to providing CME that is balanced, objective, and evidenced-based. In accordance with the Accreditation Council for Continuing Medical Education Standards for Integrity and Independence all parties involved in content development are required to disclose all conflicts of interest with ACCME defined ineligible companies. The HCA Healthcare Continental Division has identified, reviewed, and mitigated all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity. The CME planning committee who are in a position to control the content of this CME Activity, have no relevant financial relationships with ineligible companies to disclose
American Board of Internal Medicine (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
- 3.00 ABIM MOCSuccessful completion of this CME activity which includes participation in the evaluation component enables the participant to earn up to 3.00 ABIM MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn ABIM MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
- 3.00 AMA PRA Category 1 Credit™HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
HCA Healthcare Continental Division designates this for a maximum of 3.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 3.00 Attendance
Activity Registration Requirements
Learners must have a CME.HealthONEcares.com account to participate and complete the activity.
- Participate in the activity
- Mark their attendance via SMS code
- Complete the Survey & Activity Evaluation
Learners who complete the requirements above will receive the designated credits they are eligible for. Learners interested in CME credit must verify their profession is listed in their profile in order to be eligible for credits.
This is a live course - hardware and/or software is not required.
For our online courses we recommend the following hardware/software to successfully view and complete the contents of this course:
|Recommended Desktop Parameters
|For ease of use, we strongly recommend using a desktop computer to complete this course. The following desktop web browsers are compatible with our system:
Desktop: Chrome, Internet Explorer, MS Edge, Safari
|Recommended Mobile Parameters
|While not recommended, if you are familiar with completing courses online you may complete this course using a mobile device. For those wishing to complete this activity on Mobile, the following systems are recommended:
Apple iPhones and iPad devices on iOS 10 or later
If you encounter any issues while accessing our courses, please contact CME@HealthONEcares.com